HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Byoung Geol Choi Selected Research

Coronary Vasospasm (Coronary Artery Vasospasm)

5/2022Impact of drug-eluting stent-associated coronary artery spasm on 3-year clinical outcomes: A propensity score matching analysis.
11/2018Impact of Insulin Resistance on Acetylcholine-Induced Coronary Artery Spasm in Non-Diabetic Patients.
4/2018Impact of Trimetazidine Treatment on 5-year Clinical Outcomes in Patients with Significant Coronary Artery Spasm: A Propensity Score Matching Study.
3/2018Five-year major clinical outcomes according to severity of coronary artery spasm as assessed by intracoronary acetylcholine provocation test.
1/2018Impact of alcohol drinking on acetylcholine-induced coronary artery spasm in Korean populations.
1/2018The association of chronic air pollutants with coronary artery spasm, vasospastic angina, and endothelial dysfunction.
7/2017Three-year follow-up of patients with acetylcholine-induced coronary artery spasm combined with insignificant coronary stenosis.
1/2017Impact of Diltiazem Alone versus Diltiazem with Nitrate on Five-Year Clinical Outcomes in Patients with Significant Coronary Artery Spasm.
10/2016Impact of old age on clinical and angiographic characteristics of coronary artery spasm as assessed by acetylcholine provocation test.
11/2013The impact of high sensitivity C-reactive protein level on coronary artery spasm as assessed by intracoronary acetylcholine provocation test.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Byoung Geol Choi Research Topics

Disease

34Myocardial Infarction
01/2022 - 09/2016
27Cardiovascular Diseases (Cardiovascular Disease)
10/2021 - 11/2013
13Coronary Vasospasm (Coronary Artery Vasospasm)
05/2022 - 09/2012
12Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 12/2011
12Diabetes Mellitus
01/2021 - 09/2012
8Thrombosis (Thrombus)
01/2022 - 08/2018
8Stroke (Strokes)
09/2020 - 09/2016
7Spasm (Spasms)
11/2018 - 12/2011
6Chest Pain (Chest Pains)
01/2019 - 09/2012
5ST Elevation Myocardial Infarction
01/2022 - 12/2017
5Heart Failure
01/2022 - 01/2019
5Hypertension (High Blood Pressure)
01/2022 - 09/2012
4Insulin Resistance
04/2022 - 01/2018
4Death (Near-Death Experience)
01/2021 - 01/2018
3Non-ST Elevated Myocardial Infarction
01/2022 - 01/2018
3Peripheral Arterial Disease
01/2021 - 12/2011
3Hematoma
01/2020 - 01/2018
3Pathologic Constriction (Stenosis)
10/2019 - 01/2018
2Hemorrhage
09/2020 - 01/2020
2Dyslipidemias (Dyslipidemia)
01/2020 - 12/2019
2Coronary Stenosis (Coronary Artery Stenosis)
01/2019 - 07/2017
2Chronic Limb-Threatening Ischemia
04/2015 - 03/2015
1Heart Arrest (Cardiac Arrest)
11/2019
1Atrial Fibrillation
01/2019
1Angina Pectoris
01/2019
1Anemia
12/2018
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
08/2018
1Prediabetic State (Prediabetes)
06/2018
1Infarction (Infarctions)
04/2018
1Chronic Renal Insufficiency
01/2018
1Vascular Diseases (Vascular Disease)
01/2018
1Coronary Occlusion
09/2017
1Fibrosis (Cirrhosis)
03/2014
1Aortic Valve Stenosis (Aortic Stenosis)
03/2014
1Inflammation (Inflammations)
03/2014
1Hyperlipidemias (Hyperlipidemia)
09/2012

Drug/Important Bio-Agent (IBA)

27omega-Chloroacetophenone (Mace)IBA
10/2021 - 07/2017
16Acetylcholine (Acetylcholine Chloride)FDA Link
11/2018 - 12/2011
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2022 - 02/2016
5Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2021 - 01/2016
5Angiotensin Receptor AntagonistsIBA
01/2021 - 01/2016
3LDL CholesterolIBA
01/2022 - 12/2019
3C-Reactive ProteinIBA
07/2019 - 11/2013
3Calcium Channel Blockers (Blockers, Calcium Channel)IBA
06/2019 - 01/2017
2Insulin (Novolin)FDA Link
04/2022 - 01/2020
2CholesterolIBA
01/2022 - 01/2020
2Atorvastatin (Lipitor)FDA Link
01/2021 - 01/2018
2Antihypertensive Agents (Antihypertensives)IBA
06/2020 - 01/2015
2oxidized low density lipoproteinIBA
01/2020 - 12/2019
2Blood Glucose (Blood Sugar)IBA
01/2020 - 01/2018
2Phenobarbital (Luminal)FDA Link
10/2019 - 07/2013
2Hemoglobins (Hemoglobin)IBA
12/2018 - 06/2018
2NitratesIBA
04/2018 - 01/2017
2Air Pollutants (Pollutants, Air)IBA
01/2018 - 06/2017
2LipidsIBA
11/2013 - 09/2012
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2022
1Rosuvastatin Calcium (Crestor)FDA Link
01/2021
1BESIBA
01/2021
1Clopidogrel (Plavix)FDA Link
09/2020
1Cilostazol (Pletal)FDA LinkGeneric
09/2020
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
09/2020
1Angiotensin II Type 1 Receptor BlockersIBA
01/2020
1FibrinIBA
10/2019
1Nitroglycerin (Dynamite)FDA LinkGeneric
11/2018
1Glucose (Dextrose)FDA LinkGeneric
06/2018
1Trimetazidine (Vastarel)IBA
04/2018
1Parasympatholytics (Antispasmodics)IBA
04/2018
1Uric Acid (Urate)IBA
01/2018
1Lipoprotein(a)IBA
01/2018
1pitavastatin (itavastatin)FDA Link
01/2018
1Diltiazem (Cardizem)FDA LinkGeneric
01/2017
1Vasodilator Agents (Vasodilators)IBA
01/2017
1Biomarkers (Surrogate Marker)IBA
03/2014
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
09/2012
1Triglycerides (Triacylglycerol)IBA
12/2011

Therapy/Procedure

25Percutaneous Coronary Intervention
01/2021 - 04/2015
14Therapeutics
01/2021 - 12/2011
13Drug-Eluting Stents
05/2022 - 06/2017
8Stents
01/2022 - 08/2018
3Surgical Amputation (Amputations)
01/2021 - 03/2015
1Glycemic Control
04/2022
1Limb Salvage
01/2021
1Secondary Prevention
01/2021
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2018